Watch for Amputation Warnings With Diabetes Med Invokana
July 2017
A new boxed warning about amputation with canagliflozin (Invokana, etc) will have patients asking about the safety of SGLT2 inhibitors.
This is the latest in a growing list of flozin concerns...ketoacidosis, UTIs, yeast infections, etc.
Amputations, mainly of the toe or mid-foot, are seen in about 6 in 1,000 patients taking canagliflozin per year...compared to about 3 in 1,000 patients per year on other diabetes meds.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote